Verition Fund Management LLC Voyager Therapeutics, Inc. Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 13,450 shares of VYGR stock, worth $53,934. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,450
Previous 37,006
63.65%
Holding current value
$53,934
Previous $216,000
64.81%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VYGR
# of Institutions
135Shares Held
34.4MCall Options Held
6KPut Options Held
60.4K-
Armistice Capital, LLC New York, NY5.4MShares$21.6 Million0.43% of portfolio
-
Black Rock Inc. New York, NY5.31MShares$21.3 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$15.7 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.22MShares$12.9 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.57MShares$10.3 Million0.08% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $155M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...